'This has to change': New dad, grieving mom fighting for Alberta to cover rare cancer treatment
A new dad from the Calgary area is pressing the province to fund a new cancer treatment that might improve his chances of seeing his daughter grow up.
Chris Dyment was diagnosed with bile duct cancer in April 2023 and after 12 rounds of chemotherapy, his treatment will soon end.
The 34-year-old’s daughter Courtney was born earlier this month.
“I look at my daughter and I want to be there with her," he said.
“Bile duct cancer is a very aggressive cancer and the percentages aren’t very high to begin with, so any percentage is better than none.”
Bile duct cancer, or cholangiocarcinoma (CCA), is a rare, aggressive cancer currently treated in Alberta by one drug, but if it’s unsuccessful, there is no second treatment option.
Health Canada has approved the use of the targeted therapy Pemigatinib (Pemazyre), but Alberta does not currently cover the roughly $15,000 per month cost.
Dyment desperately wants to be there for his daughter, but he knows his survival rate will drop dramatically without another treatment option.
"Obviously, I want to see her grow and without this drug, it’s almost impossible," he said.
Chris Dyment with his daughter Courtney, who was born on March 1. (Courtesy: Chris Dyment)
The pilot has not been able to work since his diagnosis and will likely be unable to afford Pemigatinib (Pemazyre).
“If this drug works, it really works. People have gotten into surgery which has saved their lives and then I can be there with my daughter when she gets married," he said.
Fighting for change
Brenda Clayton’s oldest daughter, Rebecca, was diagnosed with the rare cancer in 2020 and died in 2021, six and half months after her first-line treatment ended.
Her family has since started the charity Cholangio-hepatocellular Carcinoma Canada.
“I don’t want to see other people go through what Rebecca went through,” Clayton said.
Rebecca (front left) and Brenda (front right) Clayton seen in a family photo. Rebecca died from bile duct cancer in 2021. (Courtesy: Brenda Clayton)
Clayton said patients have an average of five months of survival off treatment unless they can find a treatment elsewhere in the world.
“This cancer is one of the few that does not have a second-line therapy to use,” she said. “This has to change and our Canadians deserve a chance at life.”
She said Quebec and countries including the United States, United Kingdom and China cover the cost of Pemigatinib.
Clayton said she will meet with Alberta Health Minister Adriana Lagrange on April 2 to discuss this.
“We recognize that people living with bile duct cancer have few treatment options and are seeking new and better ways to address this disease. At this time, Alberta is aligned with the pan-Canadian Oncology Drug Review’s Expert Review Committee,” Alberta Health said in a statement to CTV News.
“However, the pan-Canadian Pharmaceutical Alliance is presently negotiating a pricing agreement with the drug’s manufacturer. If a pricing agreement is reached, each province and territory, including Alberta, will take into consideration both the committee’s recommendation and the pricing agreement when deciding whether or not to list the drug.”
In 2022, the pan-Canadian Oncology Drug Review’s Expert Review Committee recommended Pemazyre (pemigatinib) not be reimbursed on government-sponsored drug plans due to some uncertainty about the drug’s benefits.
On March 7, 2024, the pan-Canadian Pharmaceutical Alliance started price negotiations with the manufacturer of Pemazyre.
Clayton said aside from Dyment she knows of one other Albertan waiting for the treatment.
She has also reached out to the health ministers in every province and territory in Canada, hoping to be part of a more promising future for people facing this disease.
“When she died she asked us to please continue the fight against cholangiocarcinoma.”
Dyment said he also contacted the health minister and received a similar statement as the one provided to CTV News.
CTVNews.ca Top Stories
Ontario to ban use of cellphones in school classrooms starting in September
Ontario is introducing a suite of measures that will crack down on cellphone use and vaping in schools.
BREAKING Quebec to invest $603 million to protect the French language
Quebec will invest $603 million over five years to counter the decline of French in the province, French Language Minister Jean-Francois Roberge announced Sunday.
'Do not consume': Gift Chocolate recalled due to undeclared milk, soy
The Canadian Food Inspection Agency has issued a recall for a specific chocolate brand sold in Ontario and Quebec.
Kitchener family says their 10-year-old needs life-saving drug that cost $600,000
Raneem, 10, lives with a neurological condition and liver disease and needs Cholbam, a medication, for a longer and healthier life.
Invasive and toxic hammerhead worms make themselves at home in Ontario
Ontario is now home to an invasive and toxic worm species that can grow up to three feet long and can be dangerous to small animals and pets.
Murder charge laid after man falls to death from Toronto apartment balcony
One person has been charged with second-degree murder in connection with the death of a man who fell from a balcony following an altercation inside a Toronto apartment building.
Dozens in Italy give a fascist salute on the anniversary of Mussolini's execution
Dozens of people raised their arms in the fascist salute and shouted a fascist chant during ceremonies Sunday to honor Italian dictator Benito Mussolini on the 79th anniversary of his execution.
Zendaya tennis movie ‘Challengers’ scores at weekend box office
Zendaya and castmates Mike Faist and Josh O’Connor have been on a globetrotting press tour to get the word out about Italian director Luca Guadagnino's original film, which opened in 3,477 locations in the U.S. and Canada.
What is a 'halal mortgage'? Does it make housing more accessible?
The 2024 federal budget announced on April 16 included plans to introduce “halal mortgages” as a way to increase access to home ownership.